ProductGuru Recalls

Official recall record

RAPIDPOINT 500 Blood Gas System

US FDA — Medical Devices · 2023-09-26 · United StatesClass II
Issuing authority
US FDA — Medical Devices
Recall initiated by firm
2023-09-26
Country of alert
United States
Alert level
Class II
Alert type
recall
Brand on record
Siemens Healthcare Diagnostics Inc

What the authority reported

There are potential drug interferences from Perhexiline Maleate or Atomoxetine Hydrochloride that may cause falsely elevated sodium results reported on the RAPIDPoint 500 and RAPIDPoint 500e Blood Gas Systems. The erroneous sodium levels with positive bias may lead to unrecognized hyponatremia and/or the inappropriate treatment of hypernatremia may lead to iatrogenic hyponatremia, resulted in a delay in patient diagnosis and optimal patient management.

What to do

Follow the instructions in the official notice — recall remedies (refund, repair, replacement, or disposal) are defined by the issuing authority and the responsible business, and they differ per recall. Do not rely on summaries, including this one.

Verify at the source: US FDA — Medical Devices — official record →
Record last checked against the registry on 2026-05-31.

More recalls: US FDA — Medical Devices · United States · all filters

Other recalls from this brand

All 38 official recall notices naming Siemens Healthcare Diagnostics, Inc. on this site →

ProductGuru Recalls republishes official safety information with attribution. We are not the issuing authority and this page is not advice. If this product is a medical device or medication, speak to a doctor or pharmacist. Found an error? Report it — corrections are published.